Literature DB >> 3395099

Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.

K J Klamerus1, K A Rodvold, N A Silverman, S Levitsky.   

Abstract

The effect of cardiopulmonary bypass (CPB) on the disposition of vancomycin (15 mg/kg) and of netilmicin (3 mg/kg) was studied in 10 adults. The concentration-time profile of the drug in serum and renal clearance were characterized pre-CPB, during CPB, and post-CPB. Vancomycin and netilmicin exhibited initial decreases in mean concentrations in serum of 4.0 mg/liter (16.8%) and 2.2 mg/liter (29.1%), respectively, upon initiation of CPB. Netilmicin concentrations in serum rebounded to a mean of 0.6 mg/liter (15.4%) within 90 min on CPB and then continuously decreased. Vancomycin concentrations in serum demonstrated a rebound increase of 2.3 mg/liter (23.5%) at the end of CPB when the aorta was unclamped. Mean renal clearance throughout CPB was decreased for vancomycin (58.4 to 43.4 ml/min per m2) and netilmicin (53.4 to 31.5 ml/min per m2). The rebound in vancomycin concentration in serum strongly correlated with the length of time between unclamping the aorta and coming off CPB (r = 0.94), as well as with the increase in temperature upon rewarming (r = 0.92).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395099      PMCID: PMC172243          DOI: 10.1128/AAC.32.5.631

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Homogeneous enzyme immunoassay for netilmicin.

Authors:  M Wenk; R Hemmann; F Follath
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

Review 2.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

Review 3.  Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.

Authors:  A W Karchmer
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

4.  Vancomycin blood levels during cardiac bypass surgery.

Authors:  T W Austin; J Leake; J C Coles; M M Goldbach
Journal:  Can J Surg       Date:  1981-07       Impact factor: 2.089

5.  Netilmicin prophylaxis in open-heart surgery.

Authors:  T N Stanbridge; D J Greenall
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

6.  Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat.

Authors:  J Ham; R D Miller; L Z Benet; R S Matteo; L L Roderick
Journal:  Anesthesiology       Date:  1978-11       Impact factor: 7.892

7.  Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.

Authors:  R Riva; F Albani; A Baruzzi; I Galvani; E Perucca
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

8.  Plasma propranolol before, during, and after cardiopulmonary bypass.

Authors:  J R Plachetka; N W Salomon; J G Copeland
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

9.  Loss of nitroglycerin to cardiopulmonary bypass apparatus.

Authors:  J F Dasta; J Jacobi; L S Wu; T Sokoloski; P Beckley; T E Reilley; M B Howie
Journal:  Crit Care Med       Date:  1983-01       Impact factor: 7.598

10.  Disposition of vancomycin during hemofiltration.

Authors:  G R Matzke; M B O'Connell; A J Collins; P R Keshaviah
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

View more
  8 in total

1.  Penetration of vancomycin in uninfected sternal bone.

Authors:  L Massias; C Dubois; P de Lentdecker; O Brodaty; M Fischler; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.

Authors:  Megan H Nguyen; Samantha J Eells; Jennifer Tan; Corinne T Sheth; Bassam Omari; Margarita Flores; Jeffrey Wang; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

3.  Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.

Authors:  C Martin; P Bourget; M Alaya; A Sertin; C Atlani; K Ennabli; R Said
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.

Authors:  R D Pryka; K A Rodvold; W Ting; S Levitsky; R W Frost; J T Lettieri
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

5.  Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.

Authors:  Saeed A Alqahtani; Abdullah S Alsultan; Hussain M Alqattan; Ahmed Eldemerdash; Turki B Albacker
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

6.  Penetration of vancomycin into mediastinal and cardiac tissues in humans.

Authors:  C Martin; M Alaya; M N Mallet; X Viviand; K Ennabli; R Said; P De Micco
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.

Authors:  C Martin; X Viviand; M Alaya; F Lokiec; K Ennabli; R Said; M Pecking
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Ceftriaxone disposition in open-heart surgery patients.

Authors:  G L Jungbluth; M T Pasko; T R Beam; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.